IQVIA has newly appeared among the top searched stocks.


As of 12:32 PM on the 18th, IQVIA is trading at 63,900 KRW, down 6.03% from the previous day. This represents an 18.49% decline compared to February 15. IQVIA is known as a company possessing core technology in transdermal drug delivery systems.

Today, foreigners are tentatively recorded as net buyers of 4,000 shares. Over the past five days, individual investors have been net sellers of 30,205 shares, while foreigners and institutions have been net buyers of 21,494 shares and 21,149 shares, respectively.


On February 16, IQVIA was a market issue with the headline, "Despite Celltrion's success in Phase 3 clinical trials for dementia patches, stock declines."




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing